Localization of CD44 and CD90 positive cells to the invasive front of breast tumors

Cytometry Part B - Clinical Cytometry

Volumn 78, Issue 5, 2010, Pages 287-301

  Donnenberg, Vera S ^a,b   Donnenberg, Albert D ^a,b   Zimmerlin, Ludovic ^a,c   Landreneau, Rodney J ^b   Bhargava, Rohit ^b   Wetzel, Ryan A ^a   Basse, Per ^a,b   Brufsky, Adam M ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Breast cancer; Cancer stem cells; CD117; CD133; CD44; CD90; Cytokeratin; Flow cytometry; Immunofluorescence; Immunohistochemistry

Indexed keywords

CYTOKERATIN; HERMES ANTIGEN; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; CD133 ANTIGEN; CD44 PROTEIN, HUMAN; GLYCOPROTEIN; KERATIN; LEUKOCYTE ANTIGEN; PEPTIDE; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; ARTIFACT; BREAST CANCER; CANCER STEM CELL; CARCINOGENICITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LIGHT SCATTERING; MOUSE; NONHUMAN; PLEURA EFFUSION; PRIORITY JOURNAL; TUMOR XENOGRAFT; ANIMAL TISSUE; BREAST TUMOR; CANCER INVASION; CD44+ T LYMPHOCYTE; CD90+ T LYMPHOCYTE; CELL POPULATION; CELLULAR DISTRIBUTION; T LYMPHOCYTE; TUMOR CELL; ADENOCARCINOMA; ANIMAL; DRUG SCREENING; HUMAN; IMMUNOLOGY; NONOBESE DIABETIC MOUSE; PATHOLOGY;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; ANTIGENS, THY-1; BREAST NEOPLASMS; FEMALE; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; KERATINS; MICE; MICE, INBRED NOD; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; PEPTIDES; PLEURAL EFFUSION, MALIGNANT; PROTO-ONCOGENE PROTEINS C-KIT; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77956603259     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20530     Document Type: Article

References (58)

1. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
2. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994;367:645-648.
3. Donnenberg VS, Donnenberg AD. Multiple drug resistance in cancer revisited: The cancer stem cell hypothesis. J Clin Pharmacol 2005;45:872-877.
4. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445:106-110.
5. Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra JM, Bertucci F, Jacquemier J, Xerri L, Dontu G, Stassi G, Xiao Y, Barsky SH, Birnbaum D, Viens P, Wicha MS. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 2010;16:45-55.
6. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005;65:10946-10951.
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-3988. (Pubitemid 36418143)
8. Raouf A, Zhao Y, To K, Stingl J, Delaney A, Barbara M, Iscove N, Jones S, McKinney S, Emerman J, Aparicio S, Marra M, Eaves C. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 2008;3:109-118.
9. Liu AY, Roudier MP, True LD, Liu AY, Roudier MP, True LD. Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile. Am J Pathol 2004;165:1543-1556.
10. Donnenberg VS, Landreneau RJ, Donnenberg AD. Tumorigenic stem and progenitor cells: Implications for the therapeutic index of anti-cancer agents. J Control Release 2007;122:385-391.
11. Liu YN, Zhang J, He QH, Dai X, Shen L. Isolation and characterization of epithelial progenitor cells from human fetal liver. Hepatol Res 2008;38:103-113.
12. Rizzo S, Attard G, Hudson DL. Prostate epithelial stem cells. Cell Prolif 2005;38:363-374.
13. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PW, Lam CT, Poon RT, Fan ST, Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PWK, Lam CT, Poon RTP, Fan ST. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008;13:153-166.
14. Wright M, Calcagno A, Salcido C, Carlson M, Ambudkar S, Varticovski L. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 2008;10:R10.
15. Went PT, Dirnhofer S, Bundi M, Mirlacher M, Schraml P, Mangialaio S, Dimitrijevic S, Kononen J, Lugli A, Simon R, Sauter G. Prevalence of KIT expression in human tumors. J Clin Oncol 2004;22:4514-4522.
16. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998;11:728-734.
17. Donnenberg VS, Meyer EM, Donnenberg AD. Measurement of multiple drug resistance transporter activity in putative cancer stem/progenitor cells. In: Yu J, editor. Methods in Molecular Biology. Springer, NY: Humana Press; 2009.
18. Ho MM, Ng AV, Lam S, Hung JY. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007;67:4827-4833.
19. Visus C, Ito D, Amoscato A, Maciejewska-Franczak M, Abdelsalem A, Dhir R, Shin DM, Donnenberg VS, Whiteside TL, DeLeo AB. Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer Res 2007;67:10538-10545.
20. Donnenberg AD, Donnenberg VS. Rare-event analysis in flow cytometry. Clin Lab Med 2007;27:627-652, viii.
21. Horny HP, Menke DM, Kaiserling E. Neoplastic human tissue mast cells express the adhesion molecule CD44/HCAM. Virchows Arch 1996;429:91-94.
22. Donnenberg VS, Luketich JD, Landreneau RJ, DeLoia JA, Basse P, Donnenberg AD. Tumorigenic epithelial stem cells and their normal counterparts. Ernst Schering Found Symp Proc 2006;5:245-263.
23. Zimmerlin L, Donnenberg VS, Pfeifer ME, Meyer EM, Peault B, Rubin JP, Donnenberg AD. Stromal vascular progenitors in adult human adipose tissue. Cytometry A 2010;77:22-30.
24. Ross JA, Ansell I, Hjelle JT, Miller-Hjelle MA, Dobbie JW. Phenotypic and functional characterisation of human mesothelial cells. Tissue Antig 2000;55 (Suppl):65-66.
25. Dvorakova J, Hruba A, Velebny V, Kubala L. Isolation and characterization of mesenchymal stem cell population entrapped in bone marrow collection sets. Cell Biol Int 2008;32:1116-1125.
26. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, Markham AF, Jack A, Emery P, McGonagle D. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthrit Rheum 2002;46:3349-3360.
27. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, MacLaughlin DT, Donahoe PK. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci 2006;103:11154-11159.
28. Engelmann K, Shen H, Finn OJ. MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Res 2008;68:2419-2426.
29. Harris MA, Yang H, Low BE, Mukherje J, Guha A, Bronson RT, Shultz LD, Israel MA, Yun K. Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res 2008;68:10051-10059.
30. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature 2008;456:593-598.
31. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007;1:313-323.
32. Altmannsberger M, Osborn M, Holscher A, Schauer A, Weber K. The distribution of keratin type intermediate filaments in human breast cancer. An immunohistological study. Virchows Archiv B Cell Pathol 1981;37:277-284.
33. Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor (CD44): Multiple functions, multiple forms. Cancer Cells 1991;3:347-350.
34. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
35. Zhu H, Mitsuhashi N, Klein A, Barsky LW, Weinberg K, Barr ML, Demetriou A, Wu GD. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 2006;24:928-935.
36. Yang ZF, Ngai P, Ho DW, Yu WC, Ng MNP, Lau CK, Li MLY, Tam KH, Lam CT, Poon RTP, Fan ST. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 2008;47:919-928. (Pubitemid 351449683)
37. Muller-Sieburg CE, Whitlock CA, Weissman IL. Isolation of two early B lymphocyte progenitors from mouse marrow: A committed pre-pre-B cell and a clonogenic Thy-1-lo hematopoietic stem cell. Cell 1986;44:653-662.
38. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science 1988;241:58-62.
39. Craig W, Kay R, Cutler RL, Lansdorp PM. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 1993;177:1331-1342.
40. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 1992;89:2804-2808.
41. Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Deregibus MC, Bussolati B, Camussi G. Isolation and characterization of a stem cell population from adult human liver. Stem Cells 2006;24:2840-2850.
42. Zannettino ACW, Paton S, Arthur A, Khor F, Itescu S, Gimble JM, Gronthos S. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol 2008;214:413-421.
43. Young HE, Steele TA, Bray RA, Hudson J, Floyd JA, Hawkins K, Thomas K, Austin T, Edwards C, Cuzzourt J, Duenzl M, Lucas PA, Black AC Jr. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 2001;264:51-62.
44. Moore MAS. Converging pathways in leukemogenesis and stem cell self-renewal. Exp Hematol 2005;33:719-737.
45. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat M-L, Gyorki DE, Ward T, Partanen A, Feleppa F, Huschtscha LI, Thorne HJ, Fox SB, Yan M, French JD, Brown MA, Smyth GK, Visvader JE, Lindeman GJ. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 2009;15:907-913.
46. Donnenberg VS, Donnenberg AD. 2009. Therapeutic index and the cancer stem cell paradigm. In: Bagley R, Teicher B, editors. Stem Cells and Cancer Series: Cancer Drug Discovery and Development. Springer, NY: Humana Press.
47. Edwards ST, Cruz AC, Donnelly S, Dazin PF, Schulman ES, Jones KD, Wolters PJ, Hoopes C, Dolganov GM, Fang KC. c-Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung diseases. J Pathol 2005;206:279-290.
48. Handgretinger R, Gordon PR, Leimig T, Chen X, Buhring HJ, Niethammer D, Kuci S. Biology and plasticity of CD133+ hematopoietic stem cells. Ann NY Acad Sci 2003;996:141-151. (Pubitemid 36706596)
49. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004;432:396-401.
50. Maitland NJ, Collins AT. Prostate cancer stem cells: A new target for therapy. J Clin Oncol 2008;26:2862-2870.
51. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyak K. Mol Definit Breast Tumor Heterog 2007;11:259-273.
52. Wicha M. Cancer stem cell heterogeneity in hereditary breast cancer. Breast Cancer Res 2008;10:105.
53. Andrews RG, Singer JW, Bernstein ID. Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 1989;169:1721-1731.
54. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM. Identification of pancreatic cancer stem cells. Cancer Res 2007;67:1030-1037.
55. Ginestier C, Korkaya H, Dontu G, Birnbaum D, Wicha MS, Charafe- Jauffret E. [The cancer stem cell: The breast cancer driver]. Med Sci (Paris) 2007;23:1133-1139.
56. Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 2001;264:169-184.
57. Westermarck J, Kahari V-M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999;13:781-792.
58. Taipale J, Keski-Oja J. Growth factors in the extracellular matrix. FASEB J 1997;11:51-59.